<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30123882</PMID>        <DateRevised>            <Year>2018</Year>            <Month>08</Month>            <Day>22</Day>        </DateRevised>        <Article PubModel="Electronic-eCollection">            <Journal>                <ISSN IssnType="Print">2587-0831</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>14</Volume>                    <Issue>3</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Jul</Month>                    </PubDate>                </JournalIssue>                <Title>European journal of breast health</Title>                <ISOAbbreviation>Eur J Breast Health</ISOAbbreviation>            </Journal>            <ArticleTitle>Immunohistochemical HER2 Status Evaluation in Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study.</ArticleTitle>            <Pagination>                <MedlinePgn>160-165</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.5152/ejbh.2018.3961</ELocationID>            <Abstract>                <AbstractText Label="Objective" NlmCategory="UNASSIGNED">As patients with increased human epidermal growth factor receptor (HER2) overexpression are more likely to benefit from trastuzumab treatment, the accuracy of HER2 receptor status in breast cancer patients is significant for appropriate disease management. However, this assessment is not harmonized and results may be highly variable between centers. The aim of this study was to investigate the degree of interlaboratory variability in the results of HER2 expression reported by 5 participating centers and to assess the concordance between these centers and a reference laboratory.<b>Materials and Methods</b>: A total of 30 breast cancer samples were tested and scored for HER2 expression using immunohistochemical method in 5 centers from Turkey and in a reference laboratory from Netherlands (Academic Medical Center, Amsterdam). All the participating centers had an experience of more than 10 years regarding the HER2 testing. The results were compared both among the centers and with the reference laboratory.</AbstractText>                <AbstractText Label="Results" NlmCategory="UNASSIGNED">When the concordance of participating centers and the reference laboratory was evaluated regarding negative (0-1+), equivocal 2(+) and positive 3(+) classification of HER2 immunostaining, the highest concordance was found in Center-A, and the lowest in Center-C (Kendall's tau-b concordance coefficient 0.911 and 0.724, respectively). The concordance of the centers with reference laboratory was 80.0% both in equivocal and positive samples, while it increased up to 91.8% in negative samples.</AbstractText>                <AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">This study showed that in general there is sufficiently good agreement between the reference laboratory and the participating centers for immunohistochemical HER2 assessment.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Canda</LastName>                    <ForeName>Tülay</ForeName>                    <Initials>T</Initials>                    <Identifier Source="ORCID">0000-0002-1170-3815</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Dokuz Eylül University School of Medicine, İzmir, Turkey.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Yavuz</LastName>                    <ForeName>Ekrem</ForeName>                    <Initials>E</Initials>                    <Identifier Source="ORCID">0000-0002-3166-0648</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, İstanbul University, İstanbul School of Medicine, İstanbul, Turkey.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Özdemir</LastName>                    <ForeName>Necmettin</ForeName>                    <Initials>N</Initials>                    <Identifier Source="ORCID">0000-0001-9721-7510</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Ege University School of Medicine, İzmir, Turkey.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>İlvan</LastName>                    <ForeName>Sennur</ForeName>                    <Initials>S</Initials>                    <Identifier Source="ORCID">0000-0003-1862-3794</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, İstanbul University, Cerrahpaşa School of Medicine, İstanbul, Turkey.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Dizbay</LastName>                    <ForeName>Serpil Sak</ForeName>                    <Initials>SS</Initials>                    <Identifier Source="ORCID">0000-0003-3666-3095</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Ankara University School of Medicine, Ankara, Turkey.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Durak</LastName>                    <ForeName>Merih Güray</ForeName>                    <Initials>MG</Initials>                    <Identifier Source="ORCID">0000-0003-3516-952X</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Dokuz Eylül University School of Medicine, İzmir, Turkey.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tuzlalı</LastName>                    <ForeName>Sıtkı</ForeName>                    <Initials>S</Initials>                    <Identifier Source="ORCID">0000-0002-2658-6439</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, İstanbul University, İstanbul School of Medicine, İstanbul, Turkey.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zekioğlu</LastName>                    <ForeName>Osman</ForeName>                    <Initials>O</Initials>                    <Identifier Source="ORCID">0000-0001-9728-4385</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Ege University School of Medicine, İzmir, Turkey.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Demir</LastName>                    <ForeName>Atakan</ForeName>                    <Initials>A</Initials>                    <Identifier Source="ORCID">0000-0002-1940-4086</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, İstanbul University, Cerrahpaşa School of Medicine, İstanbul, Turkey.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Onur</LastName>                    <ForeName>Handan</ForeName>                    <Initials>H</Initials>                    <Identifier Source="ORCID">0000-0002-7218-7965</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Ankara University School of Medicine, Ankara, Turkey.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Üstündağ</LastName>                    <ForeName>Kasım</ForeName>                    <Initials>K</Initials>                    <Identifier Source="ORCID">0000-0002-4786-6165</Identifier>                    <AffiliationInfo>                        <Affiliation>Clinical Research, Roche Preparations San. Inc., İstanbul, Turkey.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Göktaş</LastName>                    <ForeName>Burçe</ForeName>                    <Initials>B</Initials>                    <Identifier Source="ORCID">0000-0002-8153-0753</Identifier>                    <AffiliationInfo>                        <Affiliation>Clinical Research, Roche Preparations San. Inc., İstanbul, Turkey.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>07</Month>                <Day>01</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Turkey</Country>            <MedlineTA>Eur J Breast Health</MedlineTA>            <NlmUniqueID>101709357</NlmUniqueID>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Pathol Lab Med. 2011 Feb;135(2):233-42</RefSource>                <PMID Version="1">21284444</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Clin Pathol. 2008 Dec;130(6):883-91</RefSource>                <PMID Version="1">19019764</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mod Pathol. 2001 Nov;14(11):1079-86</RefSource>                <PMID Version="1">11706067</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 1998 Sep 16;90(18):1361-70</RefSource>                <PMID Version="1">9747867</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Science. 1989 May 12;244(4905):707-12</RefSource>                <PMID Version="1">2470152</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Pathol Lab Med. 2014 May;138(5):595-601</RefSource>                <PMID Version="1">24236805</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Science. 1987 Jan 9;235(4785):177-82</RefSource>                <PMID Version="1">3798106</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Semin Cancer Biol. 1995 Jun;6(3):135-45</RefSource>                <PMID Version="1">7495981</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Mammary Gland Biol Neoplasia. 1997 Apr;2(2):97-107</RefSource>                <PMID Version="1">10882296</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2002 Jun 5;94(11):852-4</RefSource>                <PMID Version="1">12048273</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mod Pathol. 2002 Feb;15(2):116-24</RefSource>                <PMID Version="1">11850540</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 2006 Nov;42(17):2946-53</RefSource>                <PMID Version="1">16989997</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Annu Rev Biochem. 1987;56:881-914</RefSource>                <PMID Version="1">3039909</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Turk Patoloji Derg. 2014;30(2):87-93</RefSource>                <PMID Version="1">24782296</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mod Pathol. 2007 May;20(5):584-91</RefSource>                <PMID Version="1">17396141</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">HER2</Keyword>            <Keyword MajorTopicYN="N">Immunohistochemistry</Keyword>            <Keyword MajorTopicYN="N">breast cancer</Keyword>            <Keyword MajorTopicYN="N">diagnosis</Keyword>        </KeywordList>        <CoiStatement>Conflict of Interest: The authors have no conflicts of interest to declare.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>01</Month>                <Day>11</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>04</Month>                <Day>19</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>21</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>21</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>21</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30123882</ArticleId>            <ArticleId IdType="doi">10.5152/ejbh.2018.3961</ArticleId>            <ArticleId IdType="pii">ejbh-14-3-160</ArticleId>            <ArticleId IdType="pmc">PMC6092158</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>